All In Biotech

Drug Trial Radar · NCT06588686

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.

Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 378 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

378

Actual

Start

Dec 9, 2024

Primary completion

May 2027

Study completion Jun 2027

Sponsor

Lead sponsor
Vicore Pharma ABIndustry
Sponsor type
Industry
Collaborators
Population Services International
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, either on top of stable IPF therapy or as monotherapy, are assessed in participants with IPF. Trial website: www.aspire-ipf.com

Conditions

  • Idiopathic Pulmonary Fibrosis (IPF)

Interventions

  • BuloxibutidDrug

    Buloxibutid

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of buloxibutid compared to placebo in participants with IPF as assessed by FVCTime frame: week 52

Locations

104 sites in 14 countries. Site status is shown where the registry gives one.

  • UAB Hospital, School of Medicine/Lung Health Center

    Birmingham, Alabama

  • Paradigm Clinical Research Centers, Inc.

    Redding, California

  • UC Davis Health System

    Sacramento, California

  • UC San Diego Medical Center - Hillcrest

    San Diego, California

  • Paradigm Clinical Research

    San Diego, California

  • National Jewish Medical and Research Center

    Denver, Colorado

  • University of Florida Health (UF Health)

    Gainesville, Florida

  • Clinical Research Specialists

    Kissimmee, Florida

  • Emory Saint Joseph's Hospital

    Atlanta, Georgia

  • Endeavor Health - Evanston Hospital

    Evanston, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • William Beaumont Hospital - Royal Oak

    Royal Oak, Michigan

  • Renown Clinical Research

    Reno, Nevada

  • Southeastern Research Center

    Winston-Salem, North Carolina

  • Cleveland Clinic - Cleveland, Department of Pulmonary Medicine

    Cleveland, Ohio

  • Summit Health - Bend

    Bend, Oregon

  • Oregon Clinic, Pulmonary, Critical Care & Sleep Medicine East

    Portland, Oregon

  • Temple University Hospital

    Philadelphia, Pennsylvania

  • Low Country Lung and Critical Care

    North Charleston, South Carolina

  • Baylor Scott & White Research Institute

    Dallas, Texas

  • El Paso Pulmonary Association

    El Paso, Texas

  • University of Utah, Health Sciences Center

    Salt Lake City, Utah

  • University of Wisconsin Clinical Science Center

    Madison, Wisconsin

  • CEMER Medical Center for Respiratory Diseases

    Buenos Aires, Argentina

  • Belgrano Clinical Research Center

    Buenos Aires, Argentina

  • CINME - Metabolic Research Center

    Buenos Aires, Argentina

  • Medical Center Dra. De Salvo

    Buenos Aires, Argentina

  • IMER Respiratory Medicine Institute

    Córdoba, Argentina

  • Breathe Comprehensive Clinical Health

    Godoy Cruz, Argentina

  • Emphysema Foundation, Pneumology

    Mar del Plata, Argentina

  • Vistalba Health Center

    Mendoza, Argentina

  • Ibamedica

    Santa Fe, Argentina

  • InnovaCiencia

    Rosario, Rosario, Argentina

  • Research Institute of Respiratory Diseases

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Flinders Medical Centre

    Adelaide, Australia

  • The Prince Charles Hospital

    Brisbane, Australia

  • Concord Repatriation General Hospital, Department of Respiratory Medicine

    Concord, Australia

  • St Vincent's Hospital, Sydney Ltd.

    Darlinghurst, Australia

  • Townsville University Hospital

    Douglas, Australia

  • Austin Hospital

    Heidelberg, Australia

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.